FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 352:104 January 6, 2005 Number 1

PDF PDA Full Text Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Cannistra, S. A.

Cancer of the Ovary . On page 2525, lines 1 and 2 of the legend for Figure 4 should have read, "In addition to patients with stage IA, grade 1 disease, those with stage IA, grade 2 disease or stage IB, grade 1 or 2 disease are often included in the low-risk category," rather than "stage IB, grade 2 or 3 disease," as printed. Also, on page 2528, reference 57 should have cited "Rose PG, Nerenstone S, Brady MF, et al. Secondary surgical cytoreduction for advanced ovarian carcinoma. N Engl J Med 2004;351:2489-97," rather than "Rose PG, Nerenstone S, Brady M, et al. A phase III randomized study of interval secondary cytoreduction in patients with suboptimal residual disease: a Gynecologic Oncology Group Study. Prog Proc Am Soc Clin Oncol 2002;21:201a. abstract," as printed. We regret the errors. This article has been corrected on the Journal's Web site at www.nejm.org.

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.